作者
Jennifer X. Qiao,D. Keith Williams,Patrice Gill,Ling Li,Derek Norris,John S. Tokarski,Jessica Wong,Huilin Qi,Yamnah A. Hafeji,Daniel P. Downes,Bill Degnen,Ying-Kai Wang,Gregory Locke,Hua Fang,Fei Yu,Songmei Xu,Joseph G. Naglich,Shouxin Zhang,Purushothama Nanjappa,Chao Dai,Lisa Chourb,J. Wesley Napoline,Richland Tester,Christine Jorge,Yixin Li,Arvind Mathur,Christopher M. Barbieri,Matthew G. Soars,Avinashnarayan Venkatanarayan,Emma Lees,R. M. Borzilleri,Ashvinikumar V. Gavai,Michael Wichroski,T. G. Murali Dhar
摘要
We describe the design, synthesis, and structure-activity relationship (SAR) of heterobifunctional RET ligand-directed degraders (LDDs) derived from three different second-generation RET inhibitors. These LDDs are composed of a target binding motif (TBM) that binds to the RET protein, a linker, and a cereblon binding motif (CBM) as the E3 ligase recognition unit. This led to the identification of a series of pyrazolopyridine-based heterobifunctional LDDs, as exemplified by compound